Timing clarification: LYB is scheduled to report today, Friday, July 31, 2026, before the U.S. market opens—not tomorrow. The earnings call begins at 11:00 a.m. EDT. (investors.lyondellbasell.com)
This should be an unusually strong quarter for LYB. The Middle East conflict sharply constrained global petrochemical supply, increased crude-linked product prices and steepened the cost curve in favor of LYB’s ethane-based North American assets.
The main question is therefore not whether Q2 improved materially from Q1. It is:
How much of the Q2 windfall survives into Q3 and beyond?
Visible consensus sources cluster around $3.20–$3.60 of adjusted EPS, with FactSet at approximately $3.44 of EPS and $9.21 billion of revenue. (barchart.com)
At roughly 323 million diluted shares, the $3.44 estimate implies about $1.1 billion of adjusted net income. Using LYB’s Q1 depreciation, interest and tax profile as a rough bridge suggests the market may be expecting approximately $1.7–$1.9 billion of adjusted EBITDA. That is an inference rather than a published consensus figure, but it illustrates the magnitude of the expected step-up from Q1’s $615 million.
| Metric | Q1 2026 |
|---|---|
| Revenue | $7.20B |
| Adjusted EPS | $0.49 |
| Adjusted EBITDA | $615M |
| Operating cash flow | $(269)M |
| Cash and equivalents | $2.6B |
| Available liquidity | $7.3B |
Q1 segment EBITDA was led by:
Management entered Q2 expecting substantial improvement in almost every business, higher operating rates, stronger polymer pricing and tighter global supply. (investors.lyondellbasell.com)
This is the centerpiece of the quarter.
In Q1, O&P Americas generated $327 million of EBITDA at an overall operating rate of approximately 85%. For Q2, management planned to raise utilization to roughly 90% and had announced:
The essential earnings questions are:
Polypropylene was described as a potential “sleeping giant” because global supply disruptions were more severe than in polyethylene while LYB had meaningful unused operating capacity. Any evidence that PP profitability materially inflected would improve the quality of the beat.
Dow’s report provides the clearest peer read-through. Dow generated $2.31 billion of Q2 operating EBITDA, versus $873 million in Q1, with higher polyethylene prices driving substantial margin expansion. But it guided to approximately $1.7 billion for Q3, citing the June North American polyethylene price decline, seasonality and maintenance. (investors.dow.com)
That read-through is simultaneously positive and cautionary for LYB:
A large headline beat accompanied by weak Q3 commentary could therefore be received poorly. Conversely, results merely around consensus could still work if management argues that Q3 EBITDA will remain resilient.
LYB’s Bayport PO/TBA facility was down beginning in March. Management previously estimated the earnings cost at approximately $25 million per week and expected the plant to restart near the end of Q2.
This creates a potentially wide outcome range:
Investors should look for:
Oxyfuels should otherwise have benefited from stronger seasonal demand, elevated crude prices and favorable U.S. margins. Methanol and acetyls were also expected to improve following the restart of La Porte operations.
LYB completed the sale of four European O&P sites on May 1. The transaction improves the remaining portfolio by removing higher-cost capacity, fixed costs and capital requirements, but the company expected to record a substantial accounting loss and made an approximately $300 million cash contribution to the divested businesses before closing.
Investors should therefore focus on:
The retained European business should have benefited from reduced imports and better polymer spreads, although higher naphtha and energy costs remain an important offset.
LYB entered 2026 with balance-sheet repair as a priority. At the end of Q1, it had approximately:
The company also reduced its quarterly dividend by 50% earlier this year and suspended discretionary repurchases, underscoring the importance of cash preservation.
Q2 cash flow may look much weaker than EBITDA because management intentionally increased production and working capital to serve higher-priced demand. Rising receivables and inventory can consume considerable cash when both selling prices and operating rates rise.
The best outcome would be:
A major EBITDA beat without corresponding confidence in full-year free cash flow would be less valuable.
APS entered Q2 with stronger demand but a temporary margin squeeze because higher polymer and logistics costs were passing through faster than contractual pricing resets.
Investors should look for evidence that:
Technology EBITDA fell to only $18 million in Q1 because of weak licensing activity and delayed catalyst shipments. Management expected Q2 results to improve toward, but remain slightly below, Q4 2025’s $80 million.
A recovery into the $60–$75 million area would be helpful, although this segment will not determine the stock reaction.
LYB is set up for an exceptional sequential earnings increase, and Dow’s report confirms that Q2 polymer economics were powerful. The bar, however, has also risen dramatically: consensus is already pricing in adjusted EPS many times Q1’s level.
The stock reaction will likely depend less on the precise Q2 beat and more on three forward-looking factors:
In short, investors should treat Q2 as the proof-of-earnings quarter—but Q3 guidance and cash conversion will determine whether the improvement deserves to be capitalized as a durable recovery or discounted as a temporary geopolitical windfall.